polyspecific integrin binding peptide- monomethyl auristatin E conjugate (TwoStep Therapeutics)

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug Namepolyspecific integrin binding peptide- monomethyl auristatin E conjugate (TwoStep Therapeutics)
Drug Alias NamePIP-MMAE
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionTubulin depolymerization inhibitorsIntegrin modulators
TargetsIntegrinTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTwoStep Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTwoStep Therapeutics Inc
Inactive CompaniesStanford University
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A